论文部分内容阅读
Targeted therapies that deliver the expected anti-tumor effects while mitigating the adverse effects are taking the cancer world by storm.The need for such therapies in non-small cell lung cancer(NSCLC),where systemic cytotoxic chemotherapies still remain